发明名称 REMEDY FOR MALIGNANT TUMOROUS ANEMIA
摘要 PURPOSE:A remedy, containing human erythropoietin as an active constituent and useful as a remedy for malignant tumorous anemia. CONSTITUTION:A remedy containing human erythropoietin as an active constituent. The erythropoietin (hereinafter abbreviated to EPO) is a glycoprotein mainly produced in the kidney and known as a humoral hematopoietic factor having action of affecting erythroblastic stem cells present in marrow to promote the differentiation to erythrocytic cells, but is found to be effective for treating anemia in animals with cancer. The human EPO can be obtained by various means and examples thereof include methods of purification from human urine, gene expression of a gene coding amino acid sequence of the human EPO in a host cell, e.g. Escherichia coli, yeast, Chinese hamster, ovarian cell, COS cell, etc. The remedy is normally administered by a method for administering the human EPO pharmaceutical containing 0.1-500mug EPO per adult 1-7times/ week.
申请公布号 JPS6230(A) 申请公布日期 1987.01.06
申请号 JP19860022928 申请日期 1986.02.06
申请人 CHUGAI PHARMACEUT CO LTD 发明人 AKAMATSU KENICHI;ONO MASAYOSHI
分类号 A61K35/14;A61K35/12;A61K35/22;A61K38/18;A61K38/22;A61P7/06;A61P35/00 主分类号 A61K35/14
代理机构 代理人
主权项
地址